IR Overview

CTD Holdings, Inc. (OTCQB: CTDH)

CTD Holdings, Inc. is a family of biotechnology growth companies based on cyclodextrin chemistry. Its individual divisions distribute and manufacture the trademarked Trappsol® and Aquaplex® cyclodextrins, cyclodextrin derivatives, and cyclodextrin complexes for biotechnology and life science companies involved in research, pharmaceutical, medical device, cosmetics and nutrition markets. Sphingo Biotechnology, Inc. is developing Trappsol® Cyclo™, an orphan drug designated product, for the treatment of Niemann Pick Type C, a rare and fatal genetic disease in young children. NanoSonic Products, Inc. operates the world's only cGMP pulse drying facility for the production of ultra-pure cyclodextrin derivatives and pharmaceutical grade Aquaplex® cyclodextrin complexes. CTD, Inc. supplies cyclodextrins to biotechnology and life science researchers around the globe from the world's largest catalog of cyclodextrins. The companies offer a wide variety of cyclodextrin related manufacturing services to worldwide customers, including custom formulation, manufacturing, and commercial scale supply of pharmaceutical grade cyclodextrin complexes.

Recent News

Company Information

CTD Holdings, Inc.
P.O. Box 1180
Alachua, FL 32616

Issue Type: Common Stock
Sector: Healthcare
Industry: Drugs

Management Team

N. Scott Fine
Chairman and CEO

Dr. Jeffrey L. Tate
Director, COO and CSO

Dr. Sharon H. Hrynkow
SVP of Medical Affairs

Investor Relations

Sitrick and Company
Wendy Tanaka
11999 San Vicente Blvd
Los Angeles, CA 90049

Transfer Agent

VStock Transfer, LLC
77 Spruce Street, Suite 201
Cedarhurst, NY 11516


WithumSmith+Brown, PC
1417 East Concord Street
Orlando, FL 32803